1. An intersectional analysis of sociodemographic disparities in Covid-19 vaccination: A nationwide register-based study in Sweden. Issue 46 (2nd November 2022) Authors: Spetz, M.; Lundberg, L.; Nwaru, C.; Li, H.; Santosa, A.; Ng, N.; Leach, S.; Gisslén, M.; Hammar, N.; Nyberg, F.; Rosvall, M. Journal: Vaccine Issue: Volume 40:Issue 46(2022) Page Start: 6640 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Improving the standard of care for all - a practical guide to developing a center of excellence. (2021) Authors: Vivian, E.; Puri, V.; Mejia, A.; Dickerman, R.; Kedia, P.; Moparty, V.; Mallow, J.; Lundberg, L.; Vo, A. Journal: HPB Issue: Volume 23(2021)Supplement 1 Page Start: S326 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P1210: IMMUNE CORRELATES OF RESPONSE TO GLOFITAMAB: BIOMARKER FINDINGS FROM A PIVOTAL PHASE II EXPANSION STUDY IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL). (23rd June 2022) Authors: Piccione, E. C.; Belousov, A.; Hamidi, H.; Carlo-Stella, C.; Dickinson, M.; Morschhauser, F.; Lundberg, L.; Humphrey, K.; Tracy, S.; Hutchings, M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1096 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. S220: GLOFITAMAB INDUCES DURABLE COMPLETE REMISSIONS AND HAS FAVORABLE SAFETY IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA AND ≥2 PRIOR THERAPIES: PIVOTAL PHASE II EXPANSION RESULTS. (23rd June 2022) Authors: Dickinson, M.; Carlo-Stella, C.; Morschhauser, F.; Bachy, E.; Corradini, P.; Iacoboni, G.; Khan, C.; Wróbel, T.; Offner, F.; Trněný, M.; Wu, S.-J.; Cartron, G.; Hertzberg, M.; Sureda, A.; Perez-Callejo, D.; Lundberg, L.; Relf, J.; Clark, E.; Humphrey, K.; Hutchings, M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗